Antifungal Agents Market Size, Share, Growth Analysis, By Drug Type(Echinocandins, Azoles, Ployenes, Allylamines), By Therapeutic Indication(Aspergillosis, Dermatophytosis, Candidiasis, and Others), By Application(Powders, Ointments, Drugs, and Pastes), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35J2113 | Region: Global | Published Date: May, 2024
Pages: 219 | Tables: 94 | Figures: 76

Antifungal Agents Market Insights

Global Antifungal Agents Market size was valued at USD 14.4 billion in 2022 and is poised to grow from USD 14.98 billion in 2023 to USD 20.5 billion by 2031, growing at a CAGR of 4% in the forecast period (2024-2031).

Antifungal agents are drugs that selectively eliminate fungal pathogens from host with minimal toxicity. Growing incidence of fungal infections and rising demand for fungal infection medications are projected to bolster the demand for antifungal agents across the forecast period. Advancements in antifungal drug discovery and development processes are also forecasted to augment antifungal agents market growth trajectory over the coming years. High investments in antifungal drug research are also a key factor that will bolster the sales of antifungal agents in the future. Underdeveloped and developing countries will be highly lucrative markets for antifungal agent providers going forward. On the contrary, antifungal resistance and limited spectrum of antifungal agents are projected to be key restraints for antifungal agents market development in the long run.

Antifungal Agents Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Antifungal Agents Market size was valued at USD 14.4 billion in 2022 and is poised to grow from USD 14.98 billion in 2023 to USD 20.5 billion by 2031, growing at a CAGR of 4% in the forecast period (2024-2031).

Antifungal agent manufacturers should invest heavily in R&D of novel agents and drugs that can be used for a wide variety of fungal infections. Antifungal agent companies can collaborate and partner with each other to fast track the development and launch of novel products going forward. 'Asperqillus', 'Alternaria', 'Sun Pharmaceutical Industries Ltd.', 'Eli Lily Company', 'Pfizer', 'GlaxoSmithKline', 'Sumitomo Dainippon Pharma Co. Ltd.', 'Bayer Healthcare', 'Glenmark', 'Novartis', 'Cosmo Pharmaceuticals NV', 'Sanofi-Aventis', 'Astellas Pharma', 'Teva Pharmaceutical Industries Ltd.', 'Merck & Co.', 'Kramer Laboratories', 'Abbott Laboratories', 'Enzon Pharmaceuticals', 'Gilead', 'Zydus Cadila Healthcare Ltd.'

Widespread antibiotic resistance and growing incidence of infectious chronic diseases are key factors responsible for increasing fungal infections among patients, which in turn, is projected to boost antifungal agent demand outlook.

Personalized Medicine: Antifungal agent vendors can collaborate and partner with personalized medicine companies to develop specialized treatments using antifungal agents for patients affected with different kinds of fungal infections. Antifungal agents companies can take advantage of advancements in different personalized medicine approaches to maximize their revenue generation.

North America is estimated to account for a substantial share of the antifungal agents market owing to rising cases of fungal infections in this region. of a developed healthcare infrastructure and growing investments in the R&D of novel antifungal drugs and medications are also contributing to the dominance of this segment over the coming years. Increasing cases of antifungal resistance in this region will also boost market growth going forward. The United States is forecasted to spearhead the demand for antifungal agents in the long run.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Antifungal Agents Market Size, Share, Growth Analysis, By Drug Type(Echinocandins, Azoles, Ployenes, Allylamines), By Therapeutic Indication(Aspergillosis, Dermatophytosis, Candidiasis, and Others), By Application(Powders, Ointments, Drugs, and Pastes), By Region - Industry Forecast 2024-2031

Antifungal Agents Market Insights

Antifungal Agents Market Report Snapshots

Want to customize this report?

FAQs

What is the market size of Antifungal Agents Market?

Who are the key vendors in the Antifungal Agents Market?

What is the key driver of Antifungal Agents Market?

What is the key market trend for Antifungal Agents Market?

Which region accounted for the largest share in Antifungal Agents Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300